OSR appoints Andreas Niethammer as Chief Medical Officer of Vaximm AG

6 hours ago 1

OSR Holdings (NASDAQ:OSRH) announced on Tuesday the appointment of Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR company developing a platform of orally administered target-specific T-cell activators.
Niethammer is an oncology expert with over two decades of

Recommended For You